The FDA is escalating its ongoing push for transparency and tougher enforcement, including publicizing complete response letters, seeking new authority over DTC drug advertising, and tightening expectations around external controls in rare disease trials. Don’t miss the latest in the industry. Source: PharmaVoice The FDA’s push for “radical transparency” is Read more…
It’s the perfect storm: TSA staffing shortages, extreme weather, constant flight delays, and airlines cutting hundreds of flights daily1. There is an in-person speaker program tonight. Your scheduled speaker wakes up to a ping on his phone at 4:30 am and finds the dreaded message: “We have been notified by Read more…
Nobody wants to be the last one to realize the shelf life of their milk has expired. Yet in biopharma marketing, it happens with speaker’s bureaus more often than most care to admit. The bureau that energetically launched your product three years ago may not be optimized to move your Read more…
Europe risks falling behind in the global BioPharma race, the FDA is working to increase accessibility to personalized treatments in rare diseases, and regulators are cracking down on unapproved compounded GLP-1 weight loss drugs. Together, these three stories show the shifting landscape of innovation, regulation, and competition shaping the BioPharma Read more…
The BioPharma industry is in rapid flux, shaped by transforming drug pipelines, the ongoing political battle over lowering drug prices, and a new rebate model for the 340B Drug Discount program. Here’s what’s shaping the latest in healthcare. Source: BioPharma International In a recent BioPharm International interview, Janice MacLennan, founder Read more…
One of the most persistent myths about broadcasts is that they are only good for new product launches. The reality is that while product launches are indeed a great time to deploy wide-reaching national broadcasts, their utility extends far beyond this single use. National broadcasts are perfect for announcing newly Read more…
The BioPharma industry is in rapid flux, shaped by rising tariffs, shifting policies, and new barriers to prescription access. Here’s a quick look at the forces driving change. Source: BioSpace The biopharma sector is entering 2026 with renewed strength following a market rebound. Analysts point to oncology, neuroscience, and immunology Read more…
Vision2Voice Healthcare Communications is honored to be named one of five winners of the 2025 BBB International Torch Awards for Ethics! V2V has previously been awarded in the USA at the regional level on five previous occasions, but this recognition marks our first on the international stage. For over a decade, Read more…
Filtering a spreadsheet to pinpoint the right expert can often feel like finding a needle in a haystack. You asked for a better solution. We listened. V2V is proud to announce our latest software application for visualizing data of Key Opinion Leader (KOL)/Key External Expert (KEE) Identification and Mapping projects. Read more…
Three recent BioPharma trends are making waves in the industry: breakthroughs in virus imaging for vaccine development, a new FDA pathway to accelerate rare disease treatments, and historic Medicare deals lowering costs for leading obesity and diabetes drugs. Here’s what’s shaping the latest in healthcare. Source: DDW.com Researchers have captured Read more…